Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04760288
Status:
WITHDRAWN
Last Update Posted:
2024-01-05
First Post:
2021-02-17
Brief Title:
A Study of Pralsetinib Versus Standard of Care SOC for Treatment of RET-Mutated Medullary Thyroid Cancer MTC
Sponsor:
Organization:
Hoffmann-La Roche